BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20005726)

  • 1. Development of carbohydrate-derived inhibitors of acid sphingomyelinase.
    Roth AG; Redmer S; Arenz C
    Bioorg Med Chem; 2010 Jan; 18(2):939-44. PubMed ID: 20005726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibition of acid sphingomyelinase by phosphoinositide analogues.
    Roth AG; Redmer S; Arenz C
    Chembiochem; 2009 Sep; 10(14):2367-74. PubMed ID: 19688786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
    Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
    Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.
    Wascholowski V; Giannis A
    Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors.
    Imagawa H; Oda M; Takemoto T; Yamauchi R; Yoshikawa T; Yamamoto H; Nishizawa M; Takahashi H; Hashimoto M; Yabiku K; Nagahama M; Sakurai J
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3868-71. PubMed ID: 20627555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastereoselective synthesis of gamma-amino-delta-hydroxy-alpha,alpha-difluorophosphonates: a vehicle for structure-activity relationship studies on SMA-7, a potent sphingomyelinase inhibitor.
    Yamagishi T; Muronoi S; Hikishima S; Shimeno H; Soeda S; Yokomatsu T
    J Org Chem; 2009 Aug; 74(16):6350-3. PubMed ID: 19610607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.
    Claus RA; Wüstholz A; Müller S; Bockmeyer CL; Riedel NH; Kinscherf R; Deigner HP
    Chembiochem; 2005 Apr; 6(4):726-37. PubMed ID: 15751001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite.
    Vázquez J; García-Jareño A; Mondragón L; Rubio-Martinez J; Pérez-Payá E; Albericio F
    ChemMedChem; 2008 Jun; 3(6):979-85. PubMed ID: 18393268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase.
    Taguchi M; Goda K; Sugimoto K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3681-4. PubMed ID: 14552757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
    Thompson LA; Liauw AY; Ramanjulu MM; Kasireddy-Polam P; Mercer SE; Maduskuie TP; Glicksman M; Roach AH; Meredith JE; Liu RQ; Combs AP; Higaki JN; Cordell B; Seiffert D; Zaczek RC; Robertson DW; Olson RE
    Bioorg Med Chem Lett; 2006 May; 16(9):2357-63. PubMed ID: 16473009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
    Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
    Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.
    Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Eur J Med Chem; 2005 Dec; 40(12):1377-83. PubMed ID: 16169127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional inhibitors of acid sphingomyelinase (FIASMAs).
    Kornhuber J; Tripal P; Gulbins E; Muehlbacher M
    Handb Exp Pharmacol; 2013; (215):169-86. PubMed ID: 23579455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor.
    Hakogi T; Taichi M; Katsumura S
    Org Lett; 2003 Aug; 5(16):2801-4. PubMed ID: 12889878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements.
    Yeh VS; Kurukulasuriya R; Madar D; Patel JR; Fung S; Monzon K; Chiou W; Wang J; Jacobson P; Sham HL; Link JT
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5408-13. PubMed ID: 16890427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
    Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
    Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases.
    Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C
    J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.